Metraipolis › archive › dc_9053956ac69a
Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer — Europe PMC PMID:41403952
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41403952
- DOI
- 10.3389/fimmu.2025.1623117
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:18:20.588Z
- SHA-256 of the archived text
a6fa06a6c89546d566bcc84e4d5c09474f05591d1c64a7466fb8665bc2efabd4- Stable URL of this page
https://metraipolis.com/documento/dc_9053956ac69a
How to cite
Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer — Europe PMC PMID:41403952 — Europe PMC (en), https://europepmc.org/article/MED/41403952 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9053956ac69a (Metraipolis archive dc_9053956ac69a, sha256 a6fa06a6c89546d566bcc84e4d5c09474f05591d1c64a7466fb8665bc2efabd4)
BibTeX
@misc{dc9053956ac69a,
title = {Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer — Europe PMC PMID:41403952},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41403952},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9053956ac69a; sha256 a6fa06a6c89546d566bcc84e4d5c09474f05591d1c64a7466fb8665bc2efabd4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41403952. Agents can read the archived copy with the MCP tool read_document.